FORTACIN - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
86362695
Word Mark
FORTACIN
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2015-07-13
Filing Date
2014-08-11
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
QUEEN, ESTHER FELICIA
Statements
Goods and Services
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2014-08-20
Primary Code
005
Correspondences
Name
CLIFFORD KENT WEBER,
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2014-08-14 | NEW APPLICATION ENTERED IN TRAM |
| 2014-08-20 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2014-11-25 | ASSIGNED TO EXAMINER |
| 2014-12-01 | NON-FINAL ACTION WRITTEN |
| 2014-12-01 | NON-FINAL ACTION E-MAILED |
| 2014-12-01 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2015-07-13 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 2015-07-13 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
